Patients may not know that these treatments are experimental or about the risks they may pose. The latest in AJC's ...
A new study published in JMIR XR and Spatial Computing demonstrates that the way virtual reality therapeutics (VRx) are ...
Results of the Phase III COMPETE clinical trial show that the targeted radiotherapeutic agent [177 Lu]Lu-edotreotide significantly prolonged progression-free survival in patients with metastatic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results